Related Experiment Video
Updated: Jun 15, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk
María L Cavanillas1, Antonio Alcina, Concepción Núñez
1Immunology Department, Hospital Clínico San Carlos, Madrid, Spain.
European Journal of Human Genetics : EJHG
|February 25, 2010
Summary
Genetic variations in the Interleukin-2 receptor alpha (IL2RA) gene are linked to multiple sclerosis (MS) susceptibility. This study confirms IL2RA
Area of Science:
- Immunogenetics
- Neuroimmunology
- Autoimmune Diseases
Background:
- Interleukin (IL)-2/IL-2R signaling is crucial for T cell regulation and the development of regulatory T cells.
- Genome-wide studies have identified associations between autoimmune diseases and polymorphisms in IL2/IL21, IL2RA, and IL2RB genes.
- Multiple Sclerosis (MS) is a complex autoimmune disease with a suspected genetic component involving immune system regulation.
Purpose of the Study:
- To investigate the association of polymorphisms in IL2/IL21, IL2RA, and IL2RB genes with Multiple Sclerosis (MS) susceptibility in a Spanish population.
- To validate findings through replication and meta-analysis with an independent cohort.
- To determine the independence of identified association signals within the IL2RA gene.
Main Methods:
- Genotyping of polymorphisms in IL2/IL21, IL2RA, and IL2RB genes in 430 MS patients and 550 controls from Madrid.
- Replication and meta-analysis using an independent cohort of 771 MS patients and 759 controls from Andalucía.
- Statistical analysis including Mantel-Haenszel methods and regression analyses to assess genetic associations and signal independence.
Main Results:
- Confirmed significant associations between specific IL2RA polymorphisms (rs2104286, rs11594656/rs35285258, rs41295061) and MS susceptibility.
- Observed a trend for association with the IL2/IL21 gene polymorphism (rs6822844) but no significant association for IL2RB.
- Regression analyses indicated that two IL2RA association signals (rs2104286 and rs11594656/rs35285258) are independent.
Conclusions:
- The IL2RA gene plays a significant role in MS susceptibility, supporting its involvement in common autoimmune disease risk.
- The suggestive association of IL2/IL21 warrants further investigation.
- These findings highlight the importance of IL-2 pathway genetics in the pathogenesis of multiple sclerosis.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...